• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长分化因子-15 与冠状动脉粥样硬化性心脏病慢性心力衰竭严重程度的相关性。

Correlation between growth differentiation factor-15 and the severity of chronic heart failure in patients with coronary atherosclerosis.

机构信息

Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12844-12848. doi: 10.26355/eurrev_202012_24186.

DOI:10.26355/eurrev_202012_24186
PMID:33378034
Abstract

OBJECTIVE

To explore the correlation of the growth differentiation factor-15 (GDF-15) with the severity of chronic heart failure (CHF) in patients with coronary atherosclerosis.

PATIENTS AND METHODS

300 coronary atherosclerosis patients with CHF treated in our hospital from January 2019 to December 2019 and 300 healthy people (control group) were collected and retrospectively analyzed. The basic clinical information of the patients, such as age, gender, smoking/drinking history, waist-hip ratio, BMI and blood lipid were collected, and GDF-15, cystatin C and c-reactive protein (CRP) were determined. The severity of heart failure was classified.

RESULTS

No significant differences in clinical information were found such as age, gender, smoking/drinking history, waist-to-hip ratio, BMI and blood lipid. However, there were significant differences in GDF-15, cystatin C and CRP among patients with different severities of heart failure. The GDF-15 level was 582.6 ± 104.4 pg/ml in patients with grade IV heart failure and 408.4 ± 94.8 pg/ml in patients with grade I heart failure. There was a significance after GDF-15, cystatin C and CRP were adjusted (p = 0.03) and also after the clinical information and GDF-15 were adjusted (p < 0.001).

CONCLUSIONS

GDF-15 level is correlated with the CHF severity in patients with coronary atherosclerosis, indicating that it is a potential index to evaluate the CHF severity, providing clues to the biological mechanism and treatment of heart failure.

摘要

目的

探讨生长分化因子 15(GDF-15)与冠状动脉粥样硬化患者慢性心力衰竭(CHF)严重程度的相关性。

方法

收集我院 2019 年 1 月至 2019 年 12 月收治的 300 例冠状动脉粥样硬化合并 CHF 患者(观察组)和同期 300 例健康体检者(对照组)的临床资料,回顾性分析患者的基本临床资料,如年龄、性别、吸烟/饮酒史、腰臀比、BMI 及血脂等,测定 GDF-15、胱抑素 C 及 C 反应蛋白(CRP),并对心力衰竭严重程度进行分级。

结果

观察组患者的年龄、性别、吸烟/饮酒史、腰臀比、BMI 及血脂等一般资料比较,差异无统计学意义(P>0.05);但不同心力衰竭严重程度患者的 GDF-15、胱抑素 C 及 CRP 比较,差异均有统计学意义(P<0.05)。其中,心功能Ⅳ级患者的 GDF-15 水平为(582.6±104.4)pg/ml,心功能Ⅰ级患者的 GDF-15 水平为(408.4±94.8)pg/ml,差异有统计学意义(P<0.05)。校正 GDF-15、胱抑素 C 及 CRP 后,差异有统计学意义(P=0.03);校正临床资料及 GDF-15 后,差异有统计学意义(P<0.001)。

结论

GDF-15 水平与冠状动脉粥样硬化患者 CHF 严重程度相关,提示其可能成为评估 CHF 严重程度的潜在指标,为心力衰竭的生物学机制及治疗提供线索。

相似文献

1
Correlation between growth differentiation factor-15 and the severity of chronic heart failure in patients with coronary atherosclerosis.生长分化因子-15 与冠状动脉粥样硬化性心脏病慢性心力衰竭严重程度的相关性。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12844-12848. doi: 10.26355/eurrev_202012_24186.
2
Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.生长分化因子-15与冠状动脉粥样硬化患者慢性心力衰竭之间的关联
Genet Mol Res. 2015 Mar 27;14(1):2225-33. doi: 10.4238/2015.March.27.8.
3
Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.长期生长分化因子 15 变化对心力衰竭和冠心病死亡的预测价值。
PLoS One. 2018 May 17;13(5):e0197497. doi: 10.1371/journal.pone.0197497. eCollection 2018.
4
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.心力衰竭中生长分化因子-15 的连续测量:缬沙坦心力衰竭试验中与疾病严重程度和预后的关系。
Circulation. 2010 Oct 5;122(14):1387-95. doi: 10.1161/CIRCULATIONAHA.109.928846. Epub 2010 Sep 20.
5
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.慢性阻塞性肺疾病患者的血浆生长分化因子15水平与亚临床冠状动脉疾病相关。
Respir Res. 2017 Feb 28;18(1):42. doi: 10.1186/s12931-017-0521-1.
6
Diagnostic value of growth differentiation factor-15 and β2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function.生长分化因子-15 和β2-微球蛋白对先天性心脏病合并慢性心力衰竭患儿的诊断价值及其与心功能的关系。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8096-8103. doi: 10.26355/eurrev_202008_22494.
7
The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.生长分化因子15与冠状动脉粥样硬化的存在及严重程度之间的关联。
Adv Med Sci. 2024 Mar;69(1):56-60. doi: 10.1016/j.advms.2024.02.003. Epub 2024 Feb 17.
8
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.生长分化因子 15 在慢性心力衰竭中的作用:来自 HF-ACTION 研究的新见解。生长分化因子 15 是一种氧化应激和炎症的标志物。
JACC Heart Fail. 2017 Oct;5(10):724-734. doi: 10.1016/j.jchf.2017.07.013.
9
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.生长分化因子-15在慢性心力衰竭患者中的预后效用
J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60. doi: 10.1016/j.jacc.2007.04.091. Epub 2007 Aug 24.
10
Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.用于心力衰竭特征描述的生物标志物——射血分数保留型与射血分数降低型心力衰竭的鉴别
Int J Cardiol. 2017 Jan 15;227:272-277. doi: 10.1016/j.ijcard.2016.11.110. Epub 2016 Nov 9.

引用本文的文献

1
Evaluation of potential mechanisms for skeletal muscle mass recovery early after left ventricular assist device implantation.左心室辅助装置植入后早期骨骼肌质量恢复的潜在机制评估。
JHLT Open. 2025 Jul 4;9:100338. doi: 10.1016/j.jhlto.2025.100338. eCollection 2025 Aug.
2
Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review.生长分化因子-15与心力衰竭患者不良结局之间的关联:一项系统文献综述
Heliyon. 2024 Aug 8;10(16):e35916. doi: 10.1016/j.heliyon.2024.e35916. eCollection 2024 Aug 30.
3
Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV.
生长分化因子-15作为动脉粥样硬化性冠状动脉斑块的生物标志物:在感染和未感染HIV人群中的价值
Front Cardiovasc Med. 2022 Aug 26;9:964650. doi: 10.3389/fcvm.2022.964650. eCollection 2022.
4
A Meta-Analysis of Growth Differentiation Factor-15 and Prognosis in Chronic Heart Failure.生长分化因子-15与慢性心力衰竭预后的Meta分析
Front Cardiovasc Med. 2021 Nov 5;8:630818. doi: 10.3389/fcvm.2021.630818. eCollection 2021.